Bloomberg: Athenahealth has five potential bidders

Amy Baxter | | Health Exec | Policy & Regulations

Athenahealth, a network-enabled services company for hospitals and ambulatory clients, has bids from at least five entities, according to a report from Bloomberg. The bidders include Bain Capital, Hellman and Friedman, Clayton, Dubiliar & Rice and TPG.

Elliott Management Corp., which currently owns 9 percent of Athenahealth, is also reportedly considering a bid, according to Bloomberg.

The potential sale of Athenahealth comes after its CEO Jonathan Bush announced he was leaving the company in June after admitting to domestic violence allegations against his former wife.

Final bids are due by the end of the month for the company, though Elliott previously said in May it was prepared to make an offer for $160 per share—above the reported new bids of $135 per share. That previous deal was rumored to be worth around $7 billion.

See the full story below:

Athenahealth Has Bidder Interest Over $135 Per Share

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Texas AG sues hospital for $10K after off-duty police barred from carrying guns
Cardiologists reflect on developing primary PCI in face of criticism and pushback
PBMs sue FTC for alleged Fifth Amendment violation
FDA issues Class I alert on Philips ventilators after 4 injuries
Trump selects Emmy-winning TV personality Dr. Oz to head CMS
FDA issues Class I recall of infusion pump batteries due to risk of burns

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”